Glaucoma is a multifactorial progressive ocular pathology, clinically presenting with damage to the retina and optic nerve, ultimately leading to blindness. Retinal ganglion cell loss in glaucoma ultimately results in vision loss. Vesl/Homer proteins are scaffolding proteins that are critical for maintaining synaptic integrity by clustering, organizing and functionally regulating synaptic proteins. Current anti-glaucoma therapies target IOP as the sole modifiable clinical parameters. Long-term pharmacotherapy and surgical treatment do not prevent gradual visual field loss as the disease progresses, highlighting the need for new complementary, alternative and comprehensive treatment approaches. Vesl/Homer expression was measured in the retinae of DBA/2J mice, a preclinical genetic glaucoma model with spontaneous mutations resulting in a phenotype reminiscent of chronic human pigmentary glaucoma. Vesl/Homer proteins were differentially expressed in the aged, glaucomatous DBA/2J retina, both at the transcriptional and translational level. Immunoreactivity for the long Vesl-1L/Homer 1c isoform, but not of the immediate early gene product Vesl-1S/Homer 1a was increased in the synaptic layers of the retina. This increased protein level of Vesl-1L/Homer 1c was correlated with phenotypes of increased disease severity and a decrease in visual performance. The increased expression of Vesl-1L/Homer 1c in the glaucomatous retina likely results in increased intracellular Ca 2+ release through enhancement of synaptic coupling. The ensuing Ca 2+ toxicity may thus activate neurodegenerative pathways and lead to the progressive loss of synaptic function in glaucoma. Our data suggest that higher levels of Vesl-1L/Homer 1c generate a more severe disease phenotype and may represent a viable target for therapy development.
Introduction
Glaucoma is a common multifactorial progressive ocular pathology and the most common cause of irreversible blindness worldwide (Cook & Foster, 2012) . Clinically, glaucoma presents with damage to the retina and optic nerve, manifesting histologically in a typical appearance of structural damage at the optic nerve head, with neuroretinal rim thinning, excavation (cupping), and sectoral retinal nerve fiber layer defects (Foster et al., 2002) .
Elevated intraocular pressure (IOP) is a major risk factor for glaucomatous optic neuropathy and currently the only target of pharmacological and surgical therapies for glaucoma (Foster et al., 2002) . However, estimates suggest that approximately onethird of patients do not have elevated IOP (Dielemans et al., 1994; Klein et al., 1992) . In addition, IOP-lowering medication typically only slows disease progression delaying the onset of significant vision loss (Pascale, Drago, & Govoni, 2012) . Thus, novel drugs complementary to IOP-lowering strategies, but targeting different aspects of the disease are urgently needed. These therapies can ideally protect retinal ganglion cells (RGCs) and the structure of the optic nerve head from elevated IOP and other pathological disease processes associated with glaucoma (Casson et al., 2012; Chang & Goldberg, 2012; Pascale, Drago, & Govoni, 2012) . This led us to measure molecular determinants of the retina that generate elevated susceptibility of RGCs to degeneration during glaucoma. Such new mechanistic insights and the identification of novel drug targets for the protection of the retina and optic nerve in glaucoma are critical for novel therapy development in glaucomatous retinopathies.
Aberrant synaptic signaling is pathophysiologically linked to aging of the nervous system and neurodegenerative disease and provides a highly clinically significant target for future drug discovery efforts. We have previously identified Vesl-1L/Homer 1c as an early indicator of neurodegeneration in a rat model for mild retinal ischemia that mimics a slow-onset neurodegeneration similar to glaucoma (Kaja et al., 2003) .
Vesl (VASP/Ena-related gene up-regulated during seizure and LTP protein)/Homer proteins belong to the family of scaffolding proteins, which are critical for maintaining synaptic integrity (Duncan, Hwang, & Koulen, 2005) and facilitating the effective conversion of extracellular into intracellular signals at excitatory synapses.
Two Vesl-1/Homer 1 isoforms are of particular interest in their regulation of synaptic activity: the short isoform Vesl-1S/Homer 1a, an immediate early gene product that is rapidly and transiently induced by high synaptic activity, and the long Vesl-1L/Homer 1c isoform, which is typically expressed constitutively (Duncan, Hwang, & Koulen, 2005) . The generally accepted mechanism is that the short immediate early gene Vesl-1S/Homer 1a gene product can competitively disturb multimerization and synaptic clustering of the long Vesl-1L/Homer 1c protein, thereby providing a cellular mechanism for control of synaptic activity (Duncan, Hwang, & Koulen, 2005) .
We herein investigated the hypothesis that Vesl/Homer 1 proteins are differentially expressed in the glaucomatous neural retina and that expression levels correlate with visual performance and disease phenotypes in a well-established preclinical model for human pigmentary glaucoma. Our data identify Vesl-1/Homer 1 proteins as a potential novel target for therapeutic approaches protecting the structure and function of the retina and optic nerve in glaucoma.
Methods

Animals
Two groups of DBA/2J mice were obtained from The Jackson Laboratory (Bar Harbor, ME), 6 weeks-and 9 months-old male animals. Mice were housed in the institutional animal facility with ad libitum access to food and water and maintained on a 12 h light/dark cycle. All experimental animal procedures were approved by the institutional animal care and use committee and performed in accordance with institutional and federal guidelines and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Behavioral analyses
Intraocular pressure was measured by applanation tonometry using a TonoPen XL (Reichert Ophthalmic Instruments, Depew, NY), as described previously (Burroughs, Kaja, & Koulen, 2011) . Three readings at the instrument's setting at a statistical reliability of 5% standard deviation were taken per eye, and the average of these readings was used for analysis.
For quantification of functional vision we used the Optomotry™ system (CerebralMechanics, Lethbridge, AB), which relies on the optomotor tracking response (Burroughs, Kaja, & Koulen, 2011; Douglas et al., 2005; .
In order to quantify visual acuity, we established the threshold of the maximum spatial frequency that results in an optomotor tracking response. The test was initiated by projecting a grating of low spatial frequency (0.042 cycles/degree [c/d] ), rotating at 12°/s at maximum 100% contrast). The contrast sensitivity threshold was determined by varying the contrast with the spatial frequency set at 0.042 c/d.
Quantitative gene expression analysis
We used the PARISTM kit (Applied Biosystems, Foster City, CA), according to the manufacturer's recommendations in order to isolate mRNA and total protein from the same tissue sample. cDNA was synthesized from total RNA using the High Capacity cDNA Archive kit (Applied Biosystems) and quantitative PCR was performed using a StepOne Plus instrument (Applied Biosystems) and dual-labeled probes specific for Homer 1a and Homer 1c, exactly as described in Mackiewicz et al. (2008) . Dual-labeled probes and oligonucleotides were purchased from Sigma-Aldrich (St. Louis, MO). Relative quantification was performed according to the method by Livak and Schmittgen (Livak & Schmittgen, 2001) . Data is presented as relative gene expression level (R Q ).
Quantitative immunoblotting
The protein concentration was determined according to the method of Lowry (Lowry et al., 1951) . Thirty-five micrograms of total protein were separated electrophoretically, transferred to nitrocellulose membranes (0.22 lm; Pall Corp., Port Washington, NY, USA), and probed with the following Homer 1 isoform-specific antibodies: goat anti-Homer 1a (1:100; sc-8922) (Giuffrida et al., 2005; Kaja et al., in press ), rabbit anti-Homer 1c (1:100; sc-20807) (Ghasemzadeh, Mueller, & Vasudevan, 2009; in press), and rabbit anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; sc-25778) (Kaja et al., in press ), all from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The two antiHomer antibodies are isoform-specific as evident by yielding bands of immunoreactivity of approx. 21 kDa and 42 kDa for Homer 1a and Homer 1c, respectively (cf. Suppl. Fig. 1 ). Secondary antibodies were horseradish peroxidase (HRP)-labeled donkey-anti rabbit IgG (1:10,000; NA9340, GE Healthcare, Piscataway, NJ, USA) and HRPlabeled donkey anti-goat IgG-HRP (1:5000; sc-2020, Santa Cruz Biotechnology). Quantification was performed by densitometry using ImageJ software (NIH, Bethesda, MD, USA). Density values were corrected for background and Homer 1 expression normalized to endogenous GAPDH expression. At least three separate immunoblots were quantified for each antibody target and the mean for each retina sample utilized for future calculations and correlation analyses.
Immunohistochemistry and microfluorimetry
Immunhistochemistry was performed essentially as described previously . Eyecups were fixed in 4% paraformaldehyde in PBS for 15 min, cryprotected in a graded series of sucrose (10-30% in PBS), and sectioned at 16 lm on a CryoCut One cryostat (Vibratome, St. Louis, MO). We used previously validated Homer 1 isoform specific antibodies (rabbit anti-Vesl-1S, 1:200; rabbit antiVesl-1L, 1:200) (Kaja et al., 2003) to identify the cell type-specific localization and distribution of Homer 1 isoforms in the retina. These antibodies were different from those used for immunoblotting experiments, and were kindly provided by Dr. K. Inokuchi, University of Toyama, Japan. Images were acquired with a Leica SP5 WLL laser-scanning confocal microscope (Leica Microsystems Inc., Buffalo Grove, IL). Expression levels were quantified by intensity line scan analysis over a 180 lm range using the Leica Application Suite Advance Fluorescence v2.6.2.1 (Leica Microsystems Inc.). Data was exported and plotted in Prism 5.0 software (GraphPad Inc., La Jolla, CA).
Statistics
Data are expressed as the mean ± standard error of the mean. Statistical significance was determined by Student's t-test analysis.
P values of less than 0.05 were considered statistically significant. For correlation analyses, a Pearson product-moment correlation coefficient (r) calculation to evaluate the strength of the association was used with the strength of the association identified as not, weakly, moderately or strongly correlated for 0.0 6 r 6 0.2, 0.2 6 r 6 0.4, 0.4 6 r 6 0.6, and 0.6 6 r 6 1.0, respectively (Bartlett, 1993; Burroughs, Kaja, & Koulen, 2011) . Prism v5.0 software (Graphpad Software Inc., La Jolla, CA) was used for statistical analysis.
Results
Aged DBA/2J mice have elevated intraocular pressure (IOP) and deficits in functional vision
In order to correlate Homer 1 expression with functional correlates of glaucoma, we measured IOP and functional vision in our experimental cohorts of 6 week-old (young) and 9 months-old (aged) DBA/2J mice.
Aged animals had significantly higher IOPs compared with the young group (29 ± 2 vs. 12 ± 0.4 mmHg, respectively; n = 5, P < 0.001; Fig. 1A ). Using the OptoMotry™ system, we next measured visual acuity and contrast sensitivity. Functional vision measured as visual acuity was markedly decreased in aged animals compared with young controls (0.503 ± 0.009 c/d vs. 0.257 ± 0.053, respectively; n = 5, P < 0.01; Fig. 1B ). At the same time, contrast sensitivity, the measured threshold for distinction of contrast at a given spatial frequency of 0.042 c/d, was increased in the aged cohort compared with the young (38.6 ± 12.9 vs. 13.3 ± 1.4%, respectively; n = 5, P < 0.05; Fig. 1C ).
Expression of Vesl/Homer is increased at the transcriptional and translational level in the retinae of aged DBA/2J mice
We subsequently investigated both mRNA and protein levels of both the long isoform, the constitutively expressed Vesl-1L/Homer 1c and of the short splice variant, the immediate early gene product Vesl-1S/Homer 1a. Relative gene expression (R Q ) of Homer 1a was not statistically significantly different in the retina of 9 months-old when compared with 6-week old DBA/2J mice, even though a trend towards higher transcriptional levels was observed (1.590 ± 0.437 vs. 1.000 ± 0.008; n = 3, P = 0.25; Fig. 2A ). In contrast, Homer 1c mRNA levels assessed as relative gene expression (R Q ) were highly statistically significantly elevated, 4.2 ± 0.8-fold higher in the aged cohort compared with young controls (n = 3, P < 0.01; Fig. 2B ).
Subsequently, we assessed whether the observed changes at the transcriptional level were reflected at the protein level based on quantification using GAPDH as an endogenous control (representative immunoblots are shown in Fig. 2C ). Similar to our results at the transcriptional level, Homer 1a expression in the aged DBA/2J retina was not different from 6 week-old animals (n = 5, P < 0.07; Fig. 2D ), while a trend towards increased Homer 1a expression (32 ± 13%) was observed. In contrast, normalized Homer 1c expression was statistically highly significantly increased by 60 ± 24% in 9 months-old retina, compared with 6 week-old controls (n = 5, P < 0.01; Fig. 2E ).
3.3. Elevated Vesl-1L/Homer 1c expression correlates with a decrease in visual function in the aged glaucomatous retina
In order to test whether Vesl/Homer isoform expression was correlated with functional disease parameters of glaucoma, we performed a Pearson product-moment correlation coefficient calculation to evaluate the strength of the association.
The short isoform, the immediate early gene product, Vesl-1S/ Homer 1a, showed a statistically significant, moderate, positive correlation with IOP (P < 0.05, R 2 = 0.451; Fig. 3A) , however, no significant correlation was identified with visual acuity (P = 0.54, R 2 = 0.049; Fig. 3B ) or contrast sensitivity (P = 0.66, R 2 = 0.025; Fig. 3D ).
In contrast, the constitutively expressed long Vesl-1L/Homer 1c isoform yielded strong associations with measures of disease severity. Specifically, Homer 1c levels were strongly, positively associated with IOP (P < 0.01, R 2 = 0.628; Fig. 3D ) and contrast sensitivity (P < 0.05, R 2 = 0.562; Fig. 3F ) and yielded a strong, negative correlation with visual acuity (P < 0.05, R 2 = 0.618; Fig. 3E ).
DBA/2J mice show increased Vesl-1/Homer 1 immunoreactivity in the neural retina
Given the strong association of increased Vesl-1L/Homer 1c protein levels with a decline in visual function in aging DBA/2J mice, we next performed immunohistochemistry and microfluorimetry in order to identify the cell types responsible for this increase.
In 6 week-old DBA/2J mice, Vesl-1S/Homer 1a immunoreactivity was diffuse and strongest in the ganglion cell layer (GCL), and both the inner (IPL) and outer plexiform layer (OPL) (Fig. 4A and  B) . In the aged, glaucomatous DBA/2J retina, Vesl-1S/Homer 1a immunoreactivity was moderately increased by approx. 50% ( Fig. 4A and B) , while the cellular localization of Vesl-1S/Homer 1a protein was similar when compared to young controls (Fig. 4A) .
Immunoreactivity for the long Vesl-1L/Homer 1c isoform strongly increased in the glaucomatous retina as assessed by microflourimetry ( Fig. 4C and D) . Immunoreactivity was punctate, indicative of synaptic staining, and strongest in the GCL, IPL and Similarly, the contrast sensitivity threshold showed evidence of impaired vision in the aged cohort and was significantly increased (n = 5, P < 0.05). Ã P < 0.05; ÃÃÃ P < 0.001. Fig. 4C ) and 2-3-fold higher in the aged compared with the young DBA/2J retina (Fig. 4D) .
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Discussion
Herein we tested the hypothesis that expression levels of Vesl-1/Homer 1 isoforms are altered in the glaucomatous neural retina and that such changes are correlated with functional markers of disease severity. Our hypothesis was based on the rationale that Vesl-1/Homer 1 plays a critical role in synaptic and intracellular calcium signaling (Duncan, Hwang, & Koulen, 2005; as the DBA/2J mouse used in the present study (Heijl et al., 2012; Schlamp et al., 2006) , it is critical to quantitatively assess disease state in any experimental cohort (Burroughs, Kaja, & Koulen, 2011) . Herein, we used the Optomotry™ system, which exploits the optomotor tracking response to measure functional vision McGill et al., 2004; Prusky et al., 2004) . The left-right asymmetry of the optomotor reflex in rodents permits quantification of functional vision independently for each eye (Douglas et al., 2005 , thereby providing for accurate, eyespecific correlational analysis. Thus, this type of analysis takes into account data points that represent a range of different levels of disease severity with respect to the physiological parameters assayed in both the young healthy and middle-aged glaucomatous animals. Our focus on young and middle aged animals representing healthy and early to mid-stage glaucomatous retinopathy conditions thereby avoids end-stage disease with its hallmarks of severe neuronal loss in the retina and absence of retina function (Schuettauf et al., 2004) , mirroring more closely what is observed clinically in glaucoma patients with respect to functional impairment (Sena, Ramchand, & Lindsley, 2010; Wilensky & Hawkins, 2001; Zulauf & Flammer, 1993) . Functional vision and IOP in our cohorts of young and aged DBA/2J mice were similar to those reported for this strain previously (Burroughs, Kaja, & Koulen, 2011; Nagaraju, Saleh, & Porciatti, 2007; Zhang et al., 2006) .
Physiological consequences of increased Vesl/Homer expression
Our results show a strong negative association between Vesl-1L/Homer 1c expression and visual function in aged, glaucomatous DBA/2J mice. Vesl-1L/Homer 1c is the long, constitutively expressed isoform (Duncan, Hwang, & Koulen, 2005) , which enhances synaptic coupling through multimerization (Hayashi et al., 2009 ) and anchoring synaptic proteins (Duncan, Hwang, & Koulen, 2005) (Fig. 5) . Binding partners of Vesl/Homer proteins include inositol 1,4,5-trisphosphate receptors (IP 3 Rs) and ryanodine receptors (RyRs) in the membranes of the endoplasmic reticulum and metabotropic glutamate receptors at the plasma membrane Mao et al., 2005; Menard & Quirion, 2012; Tu et al., 1998; Westhoff et al., 2003) . In addition to providing a critical clustering role, Homer isoforms also differentially alter the biophysical properties of RyRs (Feng et al., 2002; Hwang et al., 2003; Westhoff et al., 2003) . Expression of the neuronal type 2 RyR is unaltered in the retina of aged, glaucomatous DBA/2J mice (Huang et al., 2011) . It can therefore be speculated that increased Vesl-1L/Homer 1c expression will result in increased Ca 2+ release, if Vesl-1L/Homer 1c exerts similar effects on intracellular Ca 2+ channels in the retina. Therefore, an increased ratio of Homer 1c over Homer 1a in the aged DBA/2J retina would favor synaptic coupling (as depicted on the right in Fig. 5 ), whereas a lower Homer 1c over Homer 1a ratio as observed in young, non-glaucomatous DBA/ 2J mice would promote a homeostatic condition as shown on the left in Fig. 5 . Increased release of intracellular Ca 2+ in the aged glaucomatous retina of DBA/2J mice is thus likely to contribute to overall hyperexcitability and Ca 2+ toxicity (Chrysostomou et al., 2012) ( Fig. 5) . Furthermore, this effect generated by elevated Vesl-1L/Homer 1c levels is potentially exacerbated by increased release of Ca In contrast, expression of the short Vesl/Homer isoform did neither correlate with visual acuity nor the contrast sensitivity threshold. D-F) In contrast, Vesl-1L/Homer 1c expression correlated strongly with markers of glaucoma disease severity. Specifically, Vesl-1L/Homer 1c levels were positively associated with IOP (n = 5, P < 0.01). Furthermore, the long constitutively expressed long Vesl/Homer isoform showed a statistically significant negative association with visual acuity (n = 5, P < 0.05) and a positive association with the contrast sensitivity threshold (n = 5, P < 0.05), indicative of progressively higher Vesl-1L/Homer 1c expression as disease severity increased. 2012; Smith et al., 2005) , as occurs during glaucoma and related neurodegenerative pathologies (Chrysostomou et al., 2012; Droge & Schipper, 2007; Smaili et al., 2009) , and likely amplified through polycystin-2 intracellular Ca 2+ release channels present on the ER in the mouse retina .
Vesl/Homer proteins as potential targets for the development of intervention therapy in glaucoma
Mechanistically, the long Vesl-1L/Homer 1c isoform serves as an important scaffolding molecule that brings synaptic proteins into proximity (Duncan, Hwang, & Koulen, 2005) , while the short Vesl-1S/Homer 1a isoform can disturb this interaction through its lack of a multimerization domain and dominant negative competition for Vesl/Homer binding sites (Duncan, Hwang, & Koulen, 2005) . This makes Vesl/Homer proteins a potentially highly relevant clinical target for pharmaceutical intervention in glaucoma.
Previous studies have shown feasibility for such intervention in vitro and in vivo (Chen et al., 2012; Klugmann et al., 2005) .
Conclusion
We identified the synaptic clustering Vesl-1L/Homer 1c as strongly correlated with functional markers of disease severity of glaucoma in DBA/2J mice. Vesl-1L/Homer 1c represents a novel, druggable target for the future development of anti-glaucoma therapies aimed at reducing hyperexcitability and aberrant neuronal Ca 2+ signaling in the glaucomatous retina.
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